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Abstract: Podoconiosis is a neglected tropical disease (NTD) characterized by lower-leg swelling
(lymphedema), which is caused by long-term exposure to irritant red-clay soils found within tropical
volcanic high-altitude environments with heavy rainfall. The condition places a substantial burden
on affected people, their families and communities, including disability, economic consequences,
social exclusion, and stigma; mental disorders and distress are also common. This paper focuses on
community-based care of podoconiosis, and, in particular, the role that community involvement can
have in the reduction of stigma against people affected by podoconiosis. We first draw on research
conducted in Ethiopia for this, which has included community-based provision of care and treatment,
education, and awareness-raising, and socioeconomic rehabilitation to reduce stigma. Since people
affected by podoconiosis and other skin NTDs often suffer the double burden of mental-health illness,
which is similarly stigmatized, we then point to examples from the mental-health field in low-resource
community settings to suggest avenues for stigma reduction and increased patient engagement that
may be relevant across a range of skin NTDs, though further research is needed on this.
Keywords: podoconiosis; lymphedema; neglected tropical diseases; NTDs; mental health;
community engagement; patient involvement; stigma
1. Introduction
Podoconiosis is a neglected tropical disease (NTD), characterized by lower-leg swelling
(lymphedema), which is found in highland areas of the tropics. It has often been confused with
lymphatic filariasis, and is currently dealt with by the World Health Organization (WHO) under the
lymphatic filariasis (LF) program (link: http://www.who.int/lymphatic_filariasis/epidemiology/
podoconiosis/en/), but differs in that it is associated with long-term exposure to irritant tropical
soils [1] rather than any parasite, virus, or bacterium. These red-clay soils are found in highland
tropical areas, where ancient volcanic deposits have weathered [2] at high altitude (over 1000 m) under
conditions of heavy rainfall (over 1000 mm/year). There is now strong evidence of underlying genetic
susceptibility for podoconiosis [3], and endemic communities are usually aware that the condition
clusters in families.
Countries with a high burden of podoconiosis include Ethiopia, Uganda, Cameroon, Kenya, and
Tanzania [4]. Although rarely a direct cause of mortality, podoconiosis disables those affected through
progressive leg swelling and repeated episodes of acute dermatolymphangioadenitis. These acute
episodes occur frequently (reports vary from five [5] to 23 [6] episodes per year), and contribute
substantially to the disability and social impact associated with podoconiosis [7,8]. Research has
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explored the enormous economic burden of podoconiosis on affected communities. In a southern
Ethiopian zone of 1.5 million inhabitants, where the prevalence of podoconiosis is known to be 5.4%,
the overall cost of podoconiosis was estimated to be in excess of US$16 million per year. In this
zone, where the average income is less than US$100 per year, the direct costs to a patient were found
to be US$143 per year [9]. In addition to its economic consequences, one of the most devastating
characteristics of podoconiosis is stigma [10–12].
This article is a nonsystematic narrative review [13]. It focuses on community-based care of
podoconiosis, and, in particular, the role that community involvement can have in the reduction of
stigma against people affected by podoconiosis, but it also draws on other types of lymphedema,
such as leprosy and LF. We start by exploring the sources and consequences of stigma among people
with podoconiosis and then describe community-based approaches used to reduce stigma and provide
care in Ethiopia. We then draw on examples from the field of mental health in low-resource community
settings to suggest avenues for stigma reduction and increased patient engagement relevant across
a range of skin NTDs. To our knowledge, this is the first review on community involvement in the
care of people affected by podoconiosis, which also looks beyond NTDs to learn lessons from the
mental-health field.
2. Sources and Consequences of Stigma in Podoconiosis
Stigma has commonly been defined as an undesirable or discrediting attribute that reduces an
individual’s status in the eyes of society [14,15]. The major sources of stigma among people affected
with podoconiosis include the progressive physical disability that prevents affected individuals from
making a living [9,16]; the misconceptions among community members about the causes of the
disease and treatment options [7,17–19]; fear of public identification of a disease that is known to be
familial [18]; and the physical disfigurement caused as the disease advances [20].
People affected by podoconiosis, as is the case for people affected by other lower-limb
lymphedemas such as leprosy and LF, are stigmatized in all areas of their daily life.
Overt discrimination is common during social functions, around mate selection and marriage,
when seeking employment, and in relation to leadership roles. Due to deep-seated stigmatizing
attitudes within the community, affected individuals also experience self-stigma, manifested in the
form of low self-esteem, suicidal ideation, and avoidance of interactions with nonaffected community
members [11]. The prejudice, discrimination, and self-stigma related to podoconiosis and other
lymphedemas not only compromise the psychological and social wellbeing of patients and their
families, but also limit their access to healthcare and adherence with treatment. This causes a vicious
circle, creating further disability, illness, and reduced economic productivity. Breaking the vicious cycle
of stigma related to podoconiosis has been a top priority for community organizations and researchers
to improve the quality of life of patients and their families.
3. Community Interventions
Several community-based podoconiosis interventions have been implemented within
Ethiopia, including provision of care and treatment, education, and socioeconomic rehabilitation.
Though podoconiosis is an age-old disease, appropriate and effective means of treatment have not
been understood or available until recently. Personal efforts to treat the disease using traditional
knowledge have usually been counterproductive [21]. Most people affected by the disease therefore
live with disfigurement and disability without receiving standardized services through the formal
health system [22]. This has led to misconceptions around the possibility of cure, which, in turn,
has increased the stigmatization of affected people [21].
3.1. Community-Based Care and Treatment
Over the last two decades, NGOs and faith-based organizations have played a pioneering
role in providing care and treatment for people affected by the disease in vertically established
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outreach clinics [22,23]. In southern Ethiopia, Mossy Foot International has transformed patients
who have successfully treated themselves into Community Podoconiosis Agents. Patients who have
been educated to high-school completion are given full-time clinical training over a period of one
week, and then become responsible for identifying patients in their own community and supporting
self-care [22]. Training expert patients to provide simple, close-to-patient services is a potentially
powerful solution to lack of care in countries with low formal health-services coverage. Harnessing the
power of the local community to advocate for patients is likely to improve social support and diminish
stigma in relation to a range of dermatologic conditions [24].
By halting the progress of disability and reducing the chances of illness related to acute attacks,
the care that patients receive increases participation in community affairs and enhances their economic
productivity, thereby improving their acceptance in society. Similar benefits have been documented
for people affected by leprosy and LF, for example a leprosy self-care program in the 1990s and
other leprosy and LF programs since then. Although the main function of the leprosy self-care
groups was to encourage members to take responsibility for their own wound management, the group
members reported a number of qualitative benefits, in particular improved self-respect and dignity and
increased participation in society [25]. However, while these disease-specific examples are important,
other studies suggest that integration of care and treatment into existing health systems may provide
better opportunities to counter stigma than stand-alone vertical programs [26]. A systematic review
conducted in 2016 suggested that joint approaches to reduce stigmatization across NTDs may be
feasible given the similarities in causes, manifestations, and interventions against it [12]. Recent efforts
to integrate podoconiosis care and treatment into government health structures alongside other types
of lymphedema such as leprosy and LF are likely to play an important role in this regard [27].
3.2. Community-Based Education and Awareness
In addition to patient care and treatment, both Mossy Foot International and the International
Orthodox Christian Charities (IOCC) program (in northern Ethiopia) have utilized Community
Conversations or their equivalents to raise the awareness of the general population about podoconiosis
causes, treatment, and prevention. These programs seek to encourage people to reflect on their place in
the wider community, and to identify training, employment, and personal-development opportunities
within the community sector.
The effectiveness of community-based health education run by lay people in reducing stigma has
been confirmed in Ethiopia [28]. This study demonstrated that a health-education intervention that
included community awareness campaigns and household skill-building activities run by lay health
advisors decreased both felt and enacted stigma related to podoconiosis. In addition, awareness-raising
and education amongst healthcare staff may be equally important to counter the stigmatizing attitudes
and prejudices commonly held by them.
3.3. Community-Based Socioeconomic Rehabilitation
The final form of stigma reduction implemented in the context of podoconiosis is socioeconomic
rehabilitation. This involves skills training (e.g., carpentry, masonry, hairdressing, shoemaking,
etc.), enhancing entrepreneurship through revolving funds and loans, and providing educational
opportunities [22]. Though the impact of socioeconomic rehabilitation in the context of podoconiosis
has not been formally assessed, anecdotal evidences suggests that access to these services reduces
stigma by increasing self-reliance, self-esteem, and financial independence, and acquiring new skills
that widen opportunities for self-employment and access to public institutions. Participation in
socioeconomic rehabilitation also influences the process of social integration and social acceptance
through contributing to attitudinal change towards affected people [29].
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4. Lessons from Community Engagement for Mental Health
Mental illness shares similar characteristics to skin NTDs in that affected persons are also
heavily stigmatized and discriminated against, and are often excluded from social and economic
activities [30–32]. Furthermore, rates of mental disorder (such as depression) and distress have been
shown to be elevated amongst people with podoconiosis, LF, and other skin NTDs (which may
both be an additional cause of stigma, as well as a consequence of the NTD-related stigma) [8,33,34].
Community engagement has been shown to be effective in addressing stigma, and thereby increasing
uptake of and adherence to services, not only for NTDs such as podoconiosis and LF (as described
above) but also for mental illness. It may therefore be helpful to look beyond NTDs, to learn lessons
about community engagement from interventions used within the mental-health field, and how these
might shape holistic interventions for stigmatized skin NTDs, particularly—but not only—for those
who suffer the added burden of mental illness. However, further research on this is greatly needed.
The few studies published from low- and middle-income countries (LMICs) that have aimed to
increase uptake of mental-health services by reducing stigma in the local community have included
awareness-raising to change community knowledge and attitudes towards people with mental
illness as their core component [35–37]. A program implemented in several states in Nigeria [35,36],
for example, led to a significant increase in the use of community-based primary-care mental-health
services by training voluntary lay community health workers (CHWs) to deliver positive health
messages and challenge misconceptions around mental health, alongside a media campaign of radio
announcements, jingles, and newspaper coverage. The program highlighted the importance of regular
‘booster’ training (e.g., every six months) and supervision, plus possibly other initiatives (such as
incentives or paid work), to sustain CHWs’ enthusiasm and the effectiveness of the program over time.
Other key lessons learned from such programs have been the importance of involving and gaining
buy-in from community members and leaders and health-system leaders from the start (for example,
through forming of a stakeholder committee); linking raising awareness to the available services; and
using ‘Training of Trainers’ approaches to achieve scale-up.
A further important finding from the mental-health field has been that interventions that include
a social-contact element seem to be the most effective in reducing mental-health-related stigma and
discrimination [38,39]. This can be either through direct contact with a patient, or indirect contact such
as video testimonies, or affected persons sharing their experiences in newspapers, radio, TV, or posters.
Whilst community-based awareness-raising interventions such as the ones outlined in the sections
above may be essential in improving literacy of mental health and/or skin NTDs, it may therefore be
valuable to explore further the inclusion of social-contact components within community-engagement
interventions for skin NTDs and/or comorbid mental illness in order to increase their effectiveness.
Contact interventions have indeed already shown successes in reducing leprosy-related stigma [40].
Service-user (patient) engagement is another area that may be as important for skin NTDs as for
mental health, to empower and support affected people, and to facilitate self-care, and there are several
good cases from the leprosy and LF field [27,41–45]. Examples of mental-health programs come from
the five-year ‘Emerging mental health systems in LMICs’ (Emerald) program [46] and the seven-year
‘PRogramme for Improving Mental health carE’ (PRIME) [47], which were both implemented in
countries in Africa and Asia (Ethiopia, India, Nepal, South Africa, and Uganda; plus Nigeria for
Emerald). Both programs aimed to improve mental health care in these countries; whilst PRIME did
so by collecting evidence on the integration and scale-up of mental health services into primary health
care [47], Emerald did so by building capacity and generating evidence to enhance health-system
strengthening [46]. PRIME, which also used WHO’s widely-implemented mhGAP Intervention
Guide [48] within primary health care, included a range of community-based interventions within its
larger program, such as awareness-raising workshops, mental-health components within Community
Conversation groups, information dissemination, case detection by CHWs, community mobilization,
and community-based rehabilitation [49].
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Both Emerald and PRIME included the engagement of mental-health patients and their
families/caregivers as an important component, and acknowledged that patient involvement is
essential when developing interventions and when expanding access to integrated care services
within primary-care settings in LMICs [50]. A cross-country qualitative study conducted by Emerald
identified the main strategies for increasing patient involvement in health-system strengthening to be
patient and caregiver mobilization and empowerment; the need for capacity-building (training) of
patients/caregivers and service providers; and ensuring human rights for greater involvement [51].
Alongside this, common barriers were identified that need to be tackled and that are reminiscent of
skin NTDs, such as stigma, poverty, and power differentials in the health system, including lack of
knowledge of services and support in the local community [50–53]. To achieve capacity-building of
mental-health patients and their families/caregivers, Emerald took a country-specific multifaceted
approach that aimed to include awareness-raising, stigma reduction, information, and mobilization
and engagement of patients as its key ingredients; some of the main interventions used were
workshops with mental-health patients and their caregivers to raise awareness and mobilize for
greater advocacy and involvement, and workshops for primary-care workers and managers to
support greater patient involvement [54]. The concepts of appropriateness, reciprocity, sustainability,
and equality in partnerships were identified as being important and underpinned all capacity-building
activities [54,55]; these may be relevant beyond the mental-health field, including within skin
NTD programs.
5. Looking to the Future
While several approaches to community-based delivery of care, of education and awareness,
and of socioeconomic rehabilitation have been successfully used by podoconiosis (as well as leprosy
and LF) programs in Ethiopia and elsewhere, there is much potential for more. Socioeconomic
community-based rehabilitation in particular is an area that warrants further research.
Looking to the experience of community-based mental health services, there are still many
interventions that could potentially be applied to podoconiosis and across other stigmatized skin
conditions. Holistic approaches are needed that take into account not only the physical care of skin
NTDs, but also integrate mental-health components and take into account the complex interplay of
physical disability, mental illness, and associated stigma. At the community level, this could include
awareness-raising, not only of the implications in regards to the physical health of people affected by
skin NTDs, but also the mental-health implications (for example through awareness-raising workshops,
the inclusion of mental-health components within Community Conversation groups, or information
dissemination). Social-contact elements may be particularly useful in this respect. Similarly, patient
engagement, for example through patient groups, is vital in order to empower and support affected
people, and to facilitate self-care. Services should be integrated so that patients receive care not only
for their physical disabilities but also any mental distress or disorder; this can be achieved by making
integrated services readily available in nearby primary healthcare facilities and/or in the community,
for instance by training (and then providing regular supervision for) primary healthcare staff and/or
community health workers in case detection and/or treatment of mental disorders, as well as physical
healthcare. Stigma-reduction activities within this training may be important to counter any negative
attitudes or prejudices. Further research is required to adapt and evaluate these programs in a range of
disease and country contexts.
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